Delivery Order SPE2DB20D9329-SPE2DB25FZK10
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,136.66 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml autoinjector on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, was issued without set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL. The award...
- The Defense Logistics Agency awarded a delivery order valued at $1,712.22 to DMS Pharmaceutical Group Inc. on September 16, 2025, for the supply of Xolair 150 mg/ml auto-injector units. This award represents a firm fixed-price delivery order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA, valued at approximately $500 million and valid through November 2026. The contract carries no set-aside designation, and the place of performance is Park Ridge, Illinois,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,712.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/ml autoinjectors, with a period of performance through October 3, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml autoinjector. The contract, valued at $1,712.22 with a firm fixed-price arrangement, is set to be completed by October 9, 2025, following the award date of September 18, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $8,561.10 to DMS Pharmaceutical Group Inc. on May 27, 2025, for the supply of Xolair 150 mg/mL auto-injectors. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. The award represents a firm fixed-price delivery order with an ultimate completion date of June 17, 2025, and was made without a set-aside...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,712.22 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml auto-injectors. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will fulfill this delivery order with a completion date of September 29, 2025. This award carries no set-aside designation, allowing the vendor to compete directly in the federal procurement...
- The Defense Logistics Agency has awarded a delivery order valued at $1,712.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml auto-injectors. This firm fixed-price delivery order, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, represents a specific product draw against DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The award...
- The Defense Logistics Agency awarded a delivery order valued at $27,395.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL auto-injector medications. This firm fixed-price delivery order was issued on August 19, 2025, with an ultimate completion date of September 10, 2025, and does not utilize a set-aside designation. The award represents a specific fulfillment under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a $51,366.90 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector units. The contract, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a specific fulfillment order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. This delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $6,848.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL auto-injectors. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a discrete purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB25FZK10Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,136.66 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/mL autoinjectors. This firm fixed-price delivery order, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, represents a discrete procurement action under the company's existing Indefinite Delivery Contract with DLA. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete as a woman-owned small business in the broader federal pharmaceutical supply marketplace. DMS Pharmaceutical Group Inc., based in Park Ridge, Illinois, is an established pharmaceutical wholesaler that has served as a critical supplier within the federal healthcare supply chain since its SAM.gov registration in 2001. The company holds a substantial single-award IDC with the DLA valued at $499,999,999 through November 2026 under the SPE2DB program, which authorizes delivery orders for a comprehensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables. This Xolair delivery order exemplifies the routine procurement activities supporting Department of Defense healthcare facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 4/24/25 |